Mood Disorders  >>  Visken (pindolol)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Visken (pindolol) / Novartis
NCT00221494: Can Additional Drug Therapy Accelerate Response Time to Antidepressants

Withdrawn
4
0
US
citalopram + tiodothyronine, or + pindolol, or + placebo
Mark Frye, University of California, Los Angeles
Depression
06/06
 

Download Options